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Chronic kidney 
disease (CKD) 
matters
•  CKD is an important 
disease group that 
threatens health.
• End-stage kidney disease (ESKD) has led 
to an increasing number of dialysis and 
transplanted patients worldwide, posing 
a massive burden on health economics, 
especially in developing countries.
• ESKD resulting from hypertensive and/
or diabetic nephropathy is increasing glo-
bally, especially in the elderly. However, 
hypertension with renal dysfunction is 
an even greater problem in South Africa 
(SA), occurring in relatively young black 
patients who often also have severe target 
organ damage (heart and kidney).
• The development of CKD is associated 
with atherosclerosis caused by lifestyle-
related diseases such as obesity, hyper-
tension and diabetes. Even in the absence 
of lifestyle diseases, CKD is a risk factor 
for cardiovascular disease (CVD).
• CKD is an important disease group that is 
most likely to cause CVD, hospitalisation 
or death, thus threatening the health of 
South Africans.
• In an article by Mayosi et al.,[1] end-stage renal 
failure (ESRF) has been shown to be the fifth 
highest cause of non-traumatic death in SA.
Only estimated or deduced statistics 
exist for SA. However, with our burden 
of hypertensive ESKD, HIV nephropathy 
and other poverty-related disorders, it is 
highly likely that the sub-Saharan burden 
of CKD is far higher than that in developed 
countries. In Japan, with a population of 
>104  000 000, the prevalence of CKD was 
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Renal dysfunction or chronic kidney disease (CKD) is found in 10% of the global population and is classified into five stages according to 
the estimated glomerular filtration rate (eGFR). No matter where a patient lives, estimation of the GFR is mandatory for decision-making 
and obtained by the simple measurement of a serum creatinine level. The objective of diagnosing CKD lies in its future prevention, early 
detection and proper treatment, which will prevent or delay functional deterioration.
Primary hypertension (PH) occurs in 25% of South Africa (SA)’s black population and is the putative cause of stage 5 CKD in 40 - 60% 
of these patients. Moreover, in this group, stage 5 CKD occurs at a relatively young age (35 - 45 years) compared with other population 
groups in whom stage 5 CKD resulting from PH usually occurs between 60 and 70 years of age. In the cohort study, PH has been found in 
12 - 16% of black school learners (mean age 17 years) compared with 1.8 - 2% of other  ethnic groups (mixed race, Asian, white). End-stage 
renal failure (ESRF) is the fifth most common cause of death in SA, excluding post-traumatic cases. In addition, undiagnosed or poorly 
controlled PH is a potent risk factor for other cardiovascular disease (CVD), e.g. congestive cardiac failure, myocardial infarction, stroke. 
Significant protein is also associated with CVD and protein >1 g/d is a significant risk factor for ESRF.
S Afr Med J 2015;105(3):233-236. DOI:10.7196/SAMJ.9412
Table 1. Prevalence of adult CKD in a developed country (Japan). The number 
of patients with stage 1 or 2 CKD was estimated according to the presence of 
pathological proteinuria. Patients on dialysis (N=275 000) were excluded
CKD stage eGFR Patients, n* CKD, % (approximately)
1 ≥90 605 313 5
2 60 - 89 1 708 876 13
3 30 - 59 10 743 236 80
4 15 - 29 191 045 1.9
5 <15 45 524 0.1
eGFR = estimated glomerular filtration rate.
*Total = 13 293 985 patients.
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Fig. 1. The poorer the kidney function, the higher the risk of all-cause death, cardiovascular disease and 
hospitalisation. (GFR = glomerular filtration rate.)
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13.3 million (i.e. 12.9% of the population) 
(Table 1).[2]
A decline in kidney function is an important 
risk factor for CVD. The poorer the kidney 
function, the higher the risk of CVD. 
Besides CVD, a large-scale epidemiological 
investigation revealed that relative risks for total 
mortality or hospitalisation rise irrespective of 
cause in proportion to the degree of reduction 
in kidney function (Fig. 1).[3] 
Fig. 2 shows the relative risk of death 
from cardiovascular events according to the 
presence or absence of proteinuria and kidney 
function level. The relative risk was regarded 
as 1.0 for the cohort in the general health 
examination. This group comprised 30 704 
men and 60 668 women aged 40 - 79 years 
with an eGFR ≥60 mL/min/1.73 m² and no 
proteinuria. The age-adjusted relative risk of 
CVD mortality is shown for men and women.
Definition and 
classification of CKD
• CKD is diagnosed by proteinuria, album-
inuria, haematuria (not all cases are renal) or 
decreased glomerular filtration rate (GFR).
• CKD stages are classified according to the 
GFR. Most laboratories give a calculated 
GFR, which is derived from the serum 
creatinine value. The most commonly 
given value is the estimated GFR (eGFR).
• CKD should be appropriately treated, 
depending on its stage (Fig. 3).
Kidney Disease Improving Global Outcomes 
divides stage 3 into 3(a) and 3(b) to facilitate 
therapeutic intervention in 3(b) patients in 
whom kidney dysfunction is easily aggravated. 
Furthermore, albuminuria is categorised as normal 
(<30 µmol/d), or positive (30 - 299 µmol/d), 
and proteinuria as normal (<150 µmol/d), mild 
(150 - 490 µmol/d) and severe (≥300 µmol/d), i.e. 
categories A1, A2 and A3.
Diagnostic criteria of 
CKD
CKD is defined and described in Table 2 
and Fig. 3. It includes all morbid conditions 
associated with reduced kidney function 
indicated by the GFR or persistent findings 
that suggest kidney damage.
Instances of kidney damage:
• urinary abnormalities such as proteinuria, 
including micro albuminuria
• abnormalities of imaging tests, such as 
single kidney or polycystic kidney
• abnormalities of blood biochemistry, such 
as those indicating kidney dysfunction, 
including abnormal glomerular and 
tubular dysfunction
• abnormalities of histological findings.
The eGFR as the measurement of creatinine 
levels in blood provides vital information 
on the management of CKD. eGFR should, 
however, not be accepted as the single only 
measurement of kidney function (Table 3). 
CKD: High-risk groups
• The most important risk factor in 
SA’s black population for CKD is the 
Table 2. CKD definition
A. Obvious kidney damage shown by urinalysis, blood chemistry, images or pathology of the kidney. The presence of albuminuria or proteinuria is 
especially important. Note: Kidney cysts in the elderly do not represent CKD unless they are the result of autosomal-dominant polycystic kidney disease
B. GFR as a risk factor for ESRF: ≤60 mL/min/1.73 m² for ages 40 - 49 years and ≤40 for ages ≥70 years
Persistent evidence of A and/or B for ≥3 months 
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Fig. 2. (A): Men. (B): Women. The relative risk of cardiovascular death associated with proteinuria and 
CKD. (General population: men 30 764, women 60 668, age 40 - 79 years; reference: GFR ≥60, proteinuria 
( - ).) Data, with modification, from Irie et al.[4] (UP = proteinuria; GFR = glomerular filtration rate.)
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development of essential hypertension. In 
SA, hypertension develops much earlier 
than in developed areas of the world, is 
more severe, usually not diagnosed early, 
and often poorly treated. All of this is 
compounded by poor patient compliance.
• There are also the usual risk factors for 
the development of CKD: ageing, family 
history of CKD (including essential 
hypertension and type 2 diabetes mellitus 
(DM)), habitual use of non-steroidal anti-
inflammatory drugs (NSAIDs), history 
of abnormal urinary findings and/or 
abnormal kidney function, abnormal 
morphology of the kidney, dyslipidaemia, 
hyperuricaemia, obesity, metabolic syn-
drome, auto-immune disorders, kidney 
infections, nephrotic syndrome and kidney 
stones.
• In the SA context, the HIV epidemic is 
another relevant factor in the development 
of CKD (10% of these patients may 
develop advanced CKD). 
• Pregnancy-related factors are also important. 
Fetuses whose mothers abuse alcohol and/
or cigarettes during pregnancy or who are 
malnourished or immunocompromised are 
at risk. Infants born to these mothers have 
a high incidence of low birthweight (≤2 kg) 
and a high occurrence of subsequent severe 
CKD.
• As a safeguard against the development of 
CKD, the following basic strategies must 
be implemented:
• All individuals with a positive family 
history (i.e. parental or sibling) of 
hypertension or any other familial 
renal disease should have their blood 
pressure (BP) checked annually from 
an early age (e.g. 20 years onwards) and 
managed appropriately. Checking of BP 
should always be accompanied by urine 
dipstick testing, and abnormalities 
must be assessed by a doctor. 
• The same applies to DM patients, but 
checking should start at an older age 
(e.g. 35 years).
• Major risk factors for the above mentioned 
two disorders are lifestyle eating aber-
rations and, in particular, the excessive 
intake of dietary sodium. Obesity, which 
is often seen in SA as a societal attraction, 
must be condemned and prevented.
• The HIV epidemic must be controlled 
by all means possible.
• One of the most important causal 
factors of kidney function deterioration 
in healthy people is ageing. From about 
the age of 50 - 55 years, the GFR reduces 
by approximately 1.2 - 1.5 mL/min/year. 
This calls for careful drug administration 
with advancing age, especially drugs 
that are largely excreted by the kidneys.
• If patients with proteinuria smoke, 
are obese, or develop hypertension or 
an impaired glucose tolerance, CKD 
advances at a more rapid rate. Men are 
at particular risk; they should be put 
on stricter treatment regimens and be 
required to modify their lifestyle.
• Obesity (especially morbid obesity) is a risk 
factor for proteinuria, which can result in 
ESKD – even in the absence of diabetes or 
hypertension (especially in men).
• Dyslipidaemia is a risk factor for CVD. 
Although based on scant evidence, it has been 
suggested that dyslipidaemia may promote 
ESKD. Conversely, an increase in proteinuria 
is associated with an increased incidence and 
severity of dyslipidaemia, probably resulting 
in further proteinuria and progressive CKD.
• Hyperuricaemic patients frequently suffer 
from kidney disorders and vice versa, and 
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Fig. 3. Classification of the stages of CKD (generally referred to as CKD # where # is classified according 
to the eGFR). (GFR = glomerular filtration rate; ESKD = end-stage kidney disease.)
Table 3. Interpretation of serum creatinine
• Creatinine – not urea – is of pivotal importance in assessing GFR
• If eGFR testing reveals stage 2 CKD, repeat test twice per year. If stage 3 or 4, repeat test three or four times per year
• Factors other than GFR can influence levels of serum creatinine:
• age (progressive decrease in GFR is physiological)
• muscle bulk (lower in females, increased in males)
• diet, e.g. vegetarian 
• some drugs, e.g. cimetidine, result in a falsely high creatinine
• Examples of major pitfalls:
• a muscular man with a serum creatinine of 120 µmol/L may have a normal GFR
• conversely, a thin elderly woman with a serum creatinine of 90 µmol/L  may have reduced eGFR, e.g. <40 mL/min/1.73 m²
• Important practice point:
• A serum creatinine of  ≥150 µmol/L in females or 160 µmol/L in males indicates serious underlying renal dysfunction. These patients 
must be referred to a nephrologist
CONTINUING MEDICAL EDUCATION
236       March 2015, Vol. 105, No. 3
stages 4 - 5 CKD patients tend to have hyperuricaemia. There 
is accumulating evidence, however, that hyperuricaemia is an 
independent risk factor for atherosclerosis and progressive CKD. 
• To summarise, all individuals with a positive family history of renal 
disorders are potentially at high risk and should be regarded as such.
Sixteen dos and don’ts in the basic 
management of CKD patients
1. CKD is defined as either:
• a kidney disorder (e.g. proteinuria) with or without impairment 
of GFR, and/or
• decreased GFR, i.e. ≤60 mL/min/1.73 m² lasting for >3 months.
2.  eGFR is calculated using the so-called modification of diet in renal 
disease (MDRD) formula: 
eGFR mL/min/1.73 m² = 32 788 ↓× serum creatinine-1.154 × age-0.203 
(× 1.210 if black and × 0.742 if female)
3.  CKD is a critical risk factor for the development of CVD and ESKD. 
4.  A CKD patient should be managed by a multidisciplinary team of 
primary care physicians and nephrologists.
5.  It is desirable that patients with the following are referred to 
nephrologists:
• proteinuria 0.5 g/g creatinine or higher; or on dipstick ≥2+ 
• eGFR of <50 mL/min/1.73 m²
• proteinuria plus haematuria of ≥1+. 
6.  The treatment goal in cases of proteinuria is to achieve levels of 
<0.5 g/g creatinine, i.e. <500 µg/24 h.
7.  CKD management should be started with modification of lifestyle, 
i.e. smoking cessation, salt restriction and improvement of obesity.
8.  The goal of BP control is <130/80 mmHg and should be achieved 
gradually. Automatic home BP devices should be used whenever 
possible, and BP charts maintained and checked by doctors.
9.  Antihypertensive agents of first choice are angiotensin-converting 
enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). 
Combination with other antihypertensives should be as required but 
ACE I or A II RB should always be combined with a thiazide diuretic 
in black patients. Thiazide diuretics (other than furosemide) are 
inactive if the GFR is <30 mL/min/1.73 m².
10.  When ACE I or ARBs are used, a physician must be aware of 
the possible risk of a slight rise in the creatinine level and the 
possible occurrence of hyperkalaemia with stage 3(b), 4 or 5 
CKD patients.
11.  In diabetic nephrology, the target level of HbA1C should be 
approximately 6.5% to control the blood glucose level.
12.  The low-density lipoprotein cholesterol should be controlled at 
≤2.5 mmol/L.
13.  The primary physician should consult a nephrologist when renal 
anaemia is suspected.
14.  Physicians should consult a nephrologist whenever erythropoiesis-
stimulating agents are considered.
15.  Physicians should reduce the dose or extend the administration 
interval, depending on kidney function, when administering 
drugs that are renally excreted. 
16.  NSAIDs, contrast media and diuretics are high-grade risk factors 
for a decline (often permanent) in kidney function in patients 
with advanced CKD. The same occasionally applies with the use 
of ACE I and A II RB in stages 4 and 5 CKD,  especially in elderly, 
hypertensive or diabetic populations.
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